See Supplemental Patient Information
- Keep out of reach of pediatric patients
- Therapy is not a substitute for effective decrease of lead exposure
- Mild to moderate neutropenia has been reported in some patients receiving succimer; CBC, WBC differential and direct platelet counts should be evaluated prior to and weekly during treatment with succimer; withhold or discontinue the therapy if ANC <100/mcgL
- Instruct patient to report any signs of infection after treatment with succimer
- Symptoms associated with elevated blood lead levels may reoccur after discontinuation of therapy; closely monitor the patients for rebound of blood lead levels, by measuring blood lead levels at least once weekly until stable
- Patient receiving succimer should be adequately hydrated; use cautiously in patients with compromised renal function
- Transient mild elevations of serum transaminases have been reported in few patients during the course of succimer; monitor serum transaminases before the start of therapy and at least weekly during therapy, closely monitor the patients with a history of liver disease
- Closely monitor the patients who require repeated courses of succimer
Cautions: Use cautiously in
- Renal impairment
- Hepatic impairment
- Hx hepatic disorder
- EDTA or BAL administered within 4 weeks
Supplemental Patient Information
- Instruct patient to maintain adequate fluid intake and to promptly report any indication of infection
- Keep out of reach of pediatric patients
- Therapy is not a substitute for effective decrease of lead exposure
Pregnancy Category:C
Breastfeeding: Safety unknown. As per manufacturer data, many drugs and heavy metals are excreted in human milk, nursing mothers requiring therapy should be discouraged from nursing their infants
Drug Name: Chemet 100 MG Oral Capsule
Ingredient(s): Succimer
Imprint: CHEMET;100
Color(s): White
Shape: Capsule
Size (mm): 22.00
Score: 1
Inactive Ingredient(s): povidone / sodium starch glycolate type a potato / starch, corn / sucrose / gelatin / ferrous oxide / titanium dioxide
Drug Label Author:
Lundbeck Inc.
DEA Schedule:
Non-Scheduled
